Controlled Release Drug Delivery Market is segmented By Product (Polymer-based drug delivery system, Micro reservoir partition-controlled drug delivery system, Feedback regulated drug delivery system, Activation modulated drug delivery system (Osmotic pressure-activated drug delivery, Hydrodynamic pressure-activated drug delivery, Vapor pressure-activated drug delivery, Mechanically activated drug delivery, Magnetically activated drug delivery), Chemically activated drug delivery system (pH activated drug delivery, Hydrolysis activated drug delivery, Enzyme activated drug delivery)), By Technology (Wurster technique, Microencapsulation, Coacervation, Targeted delivery), By Route of Administration(Drug-eluting stents, Ocular implants, Nasal sprays, Transdermal patches, Infusion pumps, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Controlled Release Drug Delivery Market Size
The Global Controlled Release Drug Delivery Market reached USD 50.9 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 101.3 billion by 2031. The global controlled release drug delivery market is expected to exhibit a CAGR of 9.2% during the forecast period (2024-2031). When compared to standard drug administration methods, controlled release drug delivery devices are particularly appealing.
The changing prescription patterns of physicians who prefer controlled release drug delivery over conventional systems due to benefits such as high therapeutic efficacy, improved patient compliance, and lower treatment costs are expected to contribute to the growth of the controlled release drug delivery market.
Further more, controlled release drug delivery market size is growing rapidly because of a following factors, increased therapeutic efficacy, fewer side effects, and low treatment cost, and research and development activities. Due to the massive healthcare expenditure in countries like the U.S. and Canada, the market is seeing an increase in demand from North American regions with significant competitors like Coating Place, Inc, Corium International, Inc, Depomed, Inc, and others actively operating in the market.
Controlled Release Drug Delivery Market Scope
|
Metrics |
Details |
|
Market CAGR |
9.2% |
|
Segments Covered |
By Release Mechanism, By Technology, By Route of Administration |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North Americ |
For More Insights Request Free Sample
Controlled Release Drug Delivery Market Dynamics
Increase in Prevalence of Chronic Diseases will Drive the Growth of the Controlled Release Drug Delivery Market
The rising prevalence of chronic diseases such as diabetes, high blood pressure, cancer, and others would fuel the market's growth rate. Chronic diseases, particularly obesity and diabetes, are a major source of concern among the elderly. For instance, the rising prevalence of diabetes around the world is driving market expansion. According to the International Diabetes Federation, approximately 537 Billion individuals will have diabetes by 2021, accounting for one out of every ten people
worldwide.
It is expected to reach 643 Billion by 2030, and 783 Billion by 2045. Furthermore, three out of every four persons with diabetes live in low- and middle-income nations. Diabetes claimed one life every five seconds in 2021, accounting for nearly 6.7 Billion fatalities worldwide. Diabetes healthcare spending in 2021 is expected to be over D 966 billion, representing a 316% increase over the previous 15 years. Thus rise of diabetes will helps drive the market growth.
Rising Initiatives and Strategies by the key Companies also Drive the Market Growth
The increased activities and strategies implemented by key players to deal with the growing demand for controlled release medicine delivery are also predicted to fuel market expansion. For instance, on March 21, 2023, Ripple Therapeutics, a leading ophthalmic continuous drug delivery firm, and Hovione, a pioneer in spray drying and particle engineering, have formed a strategic agreement to expand the usage of Ripple's Epidel platform beyond ophthalmic applications.
Hovione can expand its offering of new drug delivery options to the pharmaceutical industry by including Ripple's Epidel technology into its toolbox. As a result of the aforementioned causes, the market will grow.
Lack of On-Demand Release will hamper the market growth
Developing controlled release drug delivery systems requires advanced technologies and expertise, leading to increased complexity. Thus controlled release systems are typically pre-programmed to release drugs over a specific time frame or in response to certain physiological conditions. They may not be suitable for drugs that require immediate or on-demand release, such as emergency medications or rapidly acting therapies. Thus, above factors will restrict the market growth.
Controlled Release Drug Delivery Market Segmentation Analysis
The global controlled release drug delivery market is segmented based on release mechanism, technology, route of administration and region.
The Auto-injectors/ Needle-free injectors Segment Accounted for Approximately 30.7% of the Controlled Release Drug Delivery Market Share
NFIT, also called needle-free jet injectors, harnesses the energy that is strong enough to propel a premeasured dose of a particular drug formulation, loaded in specific unique “cassettes” which are injected into the body. To take advantage of the market expansion, numerous producers of biopharmaceuticals, vaccines, and needle-free devices are engaging in strategic acquisitions and partnerships.
For instance, in April 2022, Halozyme Therapeutics, Inc. and Antares Pharma, Inc. declared that they had signed a binding contract to buy Antares Pharma ATRS for about $960 Billion. With the acquisition, Halozyme will also have access to Antares' commercial portfolio and its auto-injector drug delivery technology. The auto-injector platform will work well with Halozyme's ENHANZE technology, which creates subcutaneous injections. Thus above factors helps to drive the segment growth.
Source: DataM Intelligence Analysis (2023)
Global Controlled Release Drug Delivery Market Geographical Share
North America Accounted for Approximately 38.4% of the Market Share in 2022
Due to variables such as increased use of improved drug delivery technologies and the continuation of sophisticated treatment approaches in healthcare. Furthermore, the growing trend of self-administration of pharmaceuticals, as well as the high frequency of chronic diseases, are projected to drive market expansion throughout the forecast period.
The rising prevalence of target diseases such as cancer, neurological diseases, cardiovascular disease, and others is likely to drive demand for effective and sophisticated drug delivery methods.
According to a JAMA paper published in January 2022, around 17.1% of women and 5.6% of men in the United States reported having migraine symptoms in 2021. Furthermore, according to ACS 2023 figures, around 1,958,310 new cancer cases are predicted to be diagnosed among the population in the United States in 2023. As a result, the aforementioned variables will dominate market growth.
Source: DataM Intelligence Analysis (2023)
Controlled Release Drug Delivery Market Key Players
The major global players in the controlled release drug delivery market Johnson and Johnson, Coating Place, Inc, Corium International, Inc, Depomed, Inc, Pfizer, Inc, Biogen, GlaxoSmithKline, Novartis, Orbis Biosciences, Inc., Merck and Co and among others.
Russia Ukraine Conflict Analysis
The Russia-Ukraine conflict is estimated to have a moderate impact on the global controlled release drug delivery market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials is expectedto have little influence over the global controlled release drug delivery market growth over the forecast period.
Artificial Intelligence Analysis
AI algorithms can analyze vast amounts of data, including drug properties, release kinetics, and patient characteristics, to design optimal controlled release formulations. AI models can predict drug release profiles and optimize the composition, structure, and properties of drug delivery systems to achieve desired therapeutic outcomes. AI can assist in developing pharmacokinetic models that simulate drug release, absorption, distribution, metabolism, and excretion processes in the body.
Key Developments
- On December 23, 2021, AstraZeneca is in the process of developing the next generation of medication delivery systems. Scientists at the company are dedicated to breaking down barriers between the most promising new medication candidates and their targets in tissues and cells. Finally, these next-generation drug delivery technologies hope to transform the scientific advancement that has driven the company's breakthrough new modalities into clinical benefits for patients.
- On November 09, 2021, AMW GmbH and AdhexPharma SAS developed a strategic cooperation on AMW's transdermal delivery systems technology platform and product portfolio, combining the expertise of both firms in the field of TDS. AMW will focus on the development, marketing authorisation, and licencing of innovative transdermal delivery methods as part of the collaboration.
- In March 2022, TFF Pharmaceuticals Inc. and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) have signed a Cooperative Research and Development Agreement (CRADA).
Why Purchase the Report?
- To visualize the global controlled release drug delivery market segmentation based on release mechanism, technology, route of administration and region, as well as understandkey commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of controlled release drug delivery market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global controlled release drug delivery market report would provide approximately 53 tables, 54 figures and 195 Pages.
